HIF1A and hepatocellular carcinoma: The first study to be mentioned employed in vivo administration of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides (ASOs) in a murine model of diethyl-nitrosamine (DEN)-induced CLD and HCC [133].